Mylan secures DCGI approval for Remdesivir

Mylan N V has announced that the Drug Controller General of India (DCGI) has approved its Remdesivir 100 mg/vial for restricted emergency use in India as part of the DCGI’s accelerated approval process to address urgent, unmet needs amid the Covid-19 pandemic. Continue Reading

India’s first Covid vaccine gets nod for human trials

India’s ‘first’ indigenous COVID-19 vaccine COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with ICMR and NIV, has got the nod for human clinical trials from the Drug Controller General of India. Continue Reading